NYSCF Presents Global Stem Cell Array at NIH Workshop
News
Dr. Stephen Chang, NYSCF Vice President for Research and Development, presented the NYSCF Global Stem Cell Array technology at the National Institutes of Health Fifth AIMBE Workshop “Validation and Qualification of New In Vitro Tools and Models for the Pre-Clinical Drug Discovery Process.”
This meeting explored the latest technologies in disease modeling and drug discovery including the Array technology, NYSCF’s unique automated, robotic technology capable of producing identical human stem cell lines on an industrial scale. The purpose of this series of workshops is to develop guidelines for developing new tools for the pre-clinical and clinical drug development process, and to figure out how to validate and qualify these new technologies so that they become useful, meaningful tools.